Structure (Figure1)
Mercaptopurine Suspension
Product Images NDC 62484-1020
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Mercaptopurine (NDC 62484-1020). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nova Laboratories, Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Purixan Bottle Label (Bottle Label)
This text provides information about a medication called Mercaptopurine, produced by Nova Laboratories Ltd in the United Kingdom. The medication comes in bottles containing 2000 mg/100 mL of mercaptopurine (20 mg/mL). The text mentions dosing instructions, storage conditions, and inactive ingredients included in the medication. It is essential to shake the bottle before use and discard any unused portion after a specified period. Additional details on packaging, labeling, and approval signatures are also provided in the text.*
Purixan Carton Label (Carton Label)
Figure A (Nova 04)
Figure B (Nova 05)
Figure C (Nova 06)
Figure E (Nova 07)
Figure F (Nova 08)
Figure D (Nova 09)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
